文献速递创伤与烧伤重症综合管理与镇静镇痛

甲酰肽受体-1阻断可防止线粒体危险相关分子模式引起的受体调节并保护创伤后中性粒细胞功能

Formyl Peptide Receptor-1 Blockade Prevents Receptor Regulation by Mitochondrial Danger-Associated Molecular Patterns and Preserves Neutrophil Function After Trauma.
PubMed 文献 · Crit Care Med · 2020-01-01
一句话结论线粒体甲酰肽通过甲酰肽受体-1使中性粒细胞脱敏,POL7200/POL7178阻断该受体可防止脱敏且不抑制吞噬和活性氧产生,环孢素H在创伤后小鼠中增加肺部细菌清除。

该研究为前瞻性人类与小鼠中性粒细胞研究及临床队列分析,探讨线粒体甲酰肽如何影响中性粒细胞抗菌功能以及甲酰肽受体-1拮抗剂对这些功能的影响。线粒体甲酰肽与细菌甲酰肽对中性粒细胞的作用相似,均先激活后抑制其对趋化因子和 leukotrienes 的反应;POL7200和POL7178是人甲酰肽受体-1的特异性拮抗剂,效果优于环孢素H或抗甲酰肽受体-1抗体。甲酰肽受体-1阻断不抑制中性粒细胞细菌吞噬或活性氧产生,环孢素H在创伤后小鼠中增加肺部细菌清除。作者认为甲酰肽受体-1阻断可防止脱敏,可能既减轻全身炎症反应综合征又保护宿主抵御继发感染。

要点

  • 线粒体甲酰肽和细菌甲酰肽对中性粒细胞的作用相似,均先激活后抑制其对趋化因子和 leukotrienes 的反应。
  • POL7200和POL7178是人甲酰肽受体-1的特异性拮抗剂,效果优于环孢素H或抗甲酰肽受体-1抗体。
  • 甲酰肽受体-1阻断不抑制中性粒细胞细菌吞噬或活性氧产生。
  • 环孢素H在创伤后小鼠中增加肺部细菌清除。
  • 作者认为甲酰肽受体-1阻断可防止脱敏,可能既减轻全身炎症反应综合征又保护宿主抵御继发感染。

适用人群与场景

  • 创伤患者与志愿者对照
  • C57Bl/6、甲酰肽受体-1和甲酰肽受体-2敲除小鼠

处置流程与药物剂量

  • 人及小鼠中性粒细胞功能分别用自体线粒体碎片、线粒体甲酰肽或细菌甲酰肽激活,随后给予趋化因子或 leukotrienes。
  • 实验重复时使用甲酰肽受体-1拮抗剂环孢素H、设计的人甲酰肽受体-1拮抗剂POL7178和POL7200或抗甲酰肽受体-1抗体。
  • 小鼠采用损伤/肺部感染模型评估甲酰肽受体-1抑制的效果。

研究设计与关键结果

  • 研究类型为前瞻性人类与小鼠中性粒细胞研究及临床队列分析,场景为大学研究实验室和一级创伤中心。
  • 线粒体甲酰肽与细菌甲酰肽对中性粒细胞的作用相似。
  • 预先暴露于甲酰肽后,中性粒细胞对趋化因子和 leukotrienes 的反应受到抑制。
  • POL7200和POL7178是人甲酰肽受体-1的特异性拮抗剂,效果优于环孢素H或抗甲酰肽受体-1抗体。
  • 仅当甲酰肽受体-1存在时,甲酰肽才抑制小鼠中性粒细胞对趋化因子的反应。
  • 甲酰肽受体-1阻断不抑制中性粒细胞细菌吞噬或活性氧产生。
  • 环孢素H在创伤后增加肺部细菌清除。

证据类型、等级与局限

  • 证据类型:前瞻性人类与小鼠中性粒细胞研究及临床队列分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为甲酰肽受体-1阻断可防止脱敏,可能既减轻全身炎症反应综合征又保护宿主抵御组织创伤或原发感染后的继发感染。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: Trauma predisposes to systemic sterile inflammation (systemic inflammatory response syndrome) as well as infection, but the mechanisms linking injury to infection are poorly understood. Mitochondrial debris contains formyl peptides. These bind formyl peptide receptor-1, trafficking neutrophils to wounds, initiating systemic inflammatory response syndrome, and wound healing. Bacterial formyl peptides, however, also attract neutrophils via formyl peptide receptor-1. Thus, mitochondrial formyl peptides might suppress neutrophils antimicrobial function. Also, formyl peptide receptor-1 blockade used to mitigate systemic inflammatory response syndrome might predispose to sepsis. We examined how mitochondrial formyl peptides impact neutrophils functions contributing to antimicrobial responses and how formyl peptide receptor-1 antagonists affect those functions.

DESIGN: Prospective study of human and murine neutrophils and clinical cohort analysis.

SETTING: University research laboratory and level 1 trauma center.

PATIENTS: Trauma patients, volunteer controls.

ANIMAL SUBJECTS: C57Bl/6, formyl peptide receptor-1, and formyl peptide receptor-2 knockout mice.

INTERVENTIONS: Human and murine neutrophils functions were activated with autologous mitochondrial debris, mitochondrial formyl peptides, or bacterial formyl peptides followed by chemokines or leukotrienes. The experiments were repeated using formyl peptide receptor-1 antagonist cyclosporin H, "designer" human formyl peptide receptor-1 antagonists (POL7178 and POL7200), or anti-formyl peptide receptor-1 antibodies. Mouse injury/lung infection model was used to evaluate effect of formyl peptide receptor-1 inhibition.

MEASUREMENTS AND MAIN RESULTS: Human neutrophils cytosolic calcium, chemotaxis, reactive oxygen species production, and phagocytosis were studied before and after exposure to mitochondrial debris, mitochondrial formyl peptides, and bacterial formyl peptides. Mitochondrial formyl peptide and bacterial formyl peptides had similar effects on neutrophils. Responses to chemokines and leukotrienes were suppressed by prior exposure to formyl peptides. POL7200 and POL7178 were specific antagonists of human formyl peptide receptor-1 and more effective than cyclosporin H or anti-formyl peptide receptor-1 antibodies. Formyl peptides inhibited mouse neutrophils responses to chemokines only if formyl peptide receptor-1 was present. Formyl peptide receptor-1 blockade did not inhibit neutrophils bacterial phagocytosis or reactive oxygen species production. Cyclosporin H increased bacterial clearance in lungs after injury.

CONCLUSIONS: Formyl peptides both activate and desensitize neutrophils. Formyl peptide receptor-1 blockade prevents desensitization, potentially both diminishing systemic inflammatory response syndrome and protecting the host against secondary infection after tissue trauma or primary infection.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Itagaki K, Kaczmarek E, Kwon WY, et al. Formyl Peptide Receptor-1 Blockade Prevents Receptor Regulation by Mitochondrial Danger-Associated Molecular Patterns and Preserves Neutrophil Function After Trauma. Crit Care Med. 2020. PMID: 31939811. doi:10.1097/CCM.0000000000004094

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。